ArticleScientific reports2026
The association of first follow-up blood pressure level with recurrent stroke and mortality in survivors of spontaneous intracerebral hemorrhage.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Although blood pressure is an important modifiable factor for the prevention of recurrent stroke after spontaneous intracerebral hemorrhage (ICH), the target blood pressure remains uncertain. Using the National Health Insurance Service database from January 2005 to December 2022, patients who survived for more than one year with prescribed antihypertensive drugs were identified. We compared the risks of mortality, ischemic stroke, and recurrent ICH among six groups divided according to systolic blood pressure (SBP). SBP was assessed at the first available health examination within 1 year after the index ICH and the date of SBP measurement was defined as the index date.The incidence rates, hazard ratios, and 95% confidence intervals were estimated using the Cox proportional hazards model. Among the 11,034 ICH survivors, 5-year incidence rates of mortality, ischemic stroke, and recurrent ICH were 13.26 per 1000 person-year, 7.71, and 12.90, respectively. Mortality incidence was lowest in the SBP 120-129 mmHg group, and SBP ≥ 160 mmHg was associated with a higher risk of mortality (adjusted HR [aHR]: 1.55 [95% CI 1.06-2.28]) compared with the reference group. Acute ischemic stroke followed linear increasing trend with significance at SBP ≥ 150 mmHg (SBP 150-159 mmHg, aHR: 1.80 [95% CI 1.18-2.74]), while recurrent ICH was significantly increased at SBP ≥ 160 mmHg (aHR: 1.87 [95% CI 1.27-2.74]). The present study showed that SBP between 120-129 mmHg was associated with the lowest risk of mortality, while higher SBP levels were associated with increased risk of ischemic stroke and ICH recurrence. These findings suggest a designated blood pressure range for managing this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.